Tofacitinib blocks IFN-regulated biomarker genes in skin fibroblasts and keratinocytes in a systemic sclerosis trial is a research paper published in JCI Insight (2022). On theSindex it has a DataRank of 1.8. It has been cited 74 times, with 67 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.648
From this paper's citation signal
Citation Network Contribution
1.1
From 49 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 67 citers.
Pfizer
Grant: n/a
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: R01AR070470,K24AR063120
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: P30AR075043
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: K01AR072129
NIAID NIH HHS
Grant: UM1 AI144298
NIAMS NIH HHS
Grant: R01 AR070470
NIAMS NIH HHS
Grant: K24 AR063120
National Institutes of Health
Grant: 5K01AR072129-02
Integrative Biology Approach to Identify and Characterize Roles of lncRNAs Associated with Psoriasis Pathology
National Institutes of Health
Grant: 5K24AR063120-07
Outcomes Research in Rheumatic Diseases
National Institutes of Health
Grant: 5R01AR070470-02
Systemic Sclerosis-Associated Interstitial Lung Disease Response Index
National Institutes of Health
Grant: 5P30AR075043-04
University of Michigan Skin Biology and Diseases Resource-based Center
FWCI
8.51
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals